Search Results - "Germà, Josep Ramón"

Tumor Thymidylate Synthase 1494del6 Genotype As a Prognostic Factor in Colorectal Cancer Patients Receiving Fluorouracil-Based Adjuvant Treatment by DOTOR, Emma, CUATRECASES, Miriam, DE OCA, Javier, PEINADO, Miguel A, MORENO, Victor, GERMA, Josep Ramon, CAPELLD, Gabriel, VILLANUEVA, Alberto, MARTINEZ-INIESTA, Maria, NAVARRO, Matilde, VILARDELL, Felip, GUINO, Elisabeth, PAREJA, Laura, FIGUERAS, Agnés, MOLLEVI, David G, SERRANO, Teresa

“…The purpose of this study was to analyze the value of germline and tumor thymidylate synthase (TS) genotyping as a prognostic marker in a series of colorectal…”
Get full text

Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model by Laquente, Berta, Lacasa Salavert, Cristina, Ginestà, Mireia M, Casanovas i Casanovas, Oriol, Figueras i Amat, Agnès, Galán, Maica, García Ribas, Ignacio, Germà Lluch, José Ramón, Capellá, G. (Gabriel), Viñals Canals, Francesc

“…Gemcitabine shows a marked antitumor effect as a result of its cytotoxic action toward proliferative cells. In this article, we aim to investigate the…”
Get full text

Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel–FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice by Pernas, Sonia, Gil-Gil, Miguel, de Olza, María Ochoa, Gumà, Anna, Climent, Fina, Petit, Anna, Pla, María Jesús, García-Tejedor, Amparo, López-Ojeda, Ana, Falo, Cati, Fernandez-Otega, Adela, Mesia, Carlos, Pérez-Martin, Francisco Javier, Urruticoechea, Ander, Germà, Josep Ramon

“…One of the most efficacious primary therapies in HER2-positive breast cancer was published by the M.D. Anderson group in 2005. This randomized trial evaluated…”
Get full text

Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer by Urruticoechea, Ander, Aguilar, Helena, Solé, Xavier, Capellà, Gabriel, Martin, Lesley-Ann, Dowsett, Mitch, Germà-Lluch, Josep Ramon

“…Introduction Changes in breast cancer cell biology following hormonal treatment have been claimed as promising predictor markers of clinical benefit even…”
Get full text

Sunitinib Inhibits Tumor Growth and Synergizes with Cisplatin in Orthotopic Models of Cisplatin-Sensitive and Cisplatin-Resistant Human Testicular Germ Cell Tumors by CASTILLO-AVILA, Wilmar, PIULATS, Josep Maria, VINALS, Francesc, GARCIA DEL MURO, Xavier, VIDAL, August, CONDOM, Enric, CASANOVAS, Oriol, MORA, Josefina, RAMON GERMA, Josep, CAPELLA, Gabriel, VILLANUEVA, Alberto

“…Purpose: Germ cell tumors (GCT) of the testis are highly curable, but those patients who are refractory to cisplatin (CDDP)-based combination chemotherapy have…”
Get full text

Common genetic evolutionary pathways in familial adenomatous polyposis tumors by TARAFA, Gemma, PRAT, Esther, GERMA, Josep-Ramon, MIRO, Rosa, PEINADO, Miguel Angel, CAPELLA, Gabriel, RISQUES, Rosa-Ana, GONZALEZ, Sara, CAMPS, Jordi, GRAU, Monica, GUINO, Elisabeth, MORENO, Victor, ESTELLER, Manel, HERMAN, James G

“…Cancer cells progress through the accumulation of genetic alterations. Familial adenomatous polyposis (FAP) tumors provide an excellent model to unravel the…”
Get full text

Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma by García, Margarita, del Muro, Xavier García, Tres, Alejandro, Crespo, Carmen, Valladares, Manuel, López, Juan José, Rifà, Julio, Pérez, Xavier, Filipovich, Elena, Germà-Lluch, Josep Ramón

“…Temozolomide is a novel oral alkylating agent, active against metastatic melanoma. Combinations of chemotherapy and biological response modifiers have been…”
Get full text

CA-125 response patterns in patients with recurrent ovarian cancer treated with pegylated liposomal doxorubicin (PLD) by Oaknin, Ana, Barretina, Pilar, Pérez, Xavier, Jimenez, Laura, Velasco, Montserrat, Alsina, Maria, Brunet, Joan, Germà, Josep Ramon, Beltran, Miguel

“…: In recurrent ovarian cancer, CA-125 could be the only objective response criteria. This study analyzes response patterns regarding CA-125 in responders…”
Get more information

Molecular bases of platinum-resistance in testicular cancer by Germà-Lluch, Josep Ramon, Piulats, Josep Maria

“…Cisplatin has been the cornerstone of germ cell testicular tumors therapy since its introduction more tan 30 years ago, and a basic part of the schemes given…”
Get full text

The impact of KRAS mutations on VEGF-A production and tumour vascular network by Figueras, Agnès, Arbos, Maria Antonia, Quiles, Maria Teresa, Viñals, Francesc, Germà, Josep Ramón, Capellà, Gabriel

“…The malignant potential of tumour cells may be influenced by the molecular nature of KRAS mutations being codon 13 mutations less aggressive than codon 12…”
Get full text

A phase I clinical and pharmacokinetic study of paclitaxel and docetaxel given in combination in patients with solid tumours by Izquierdo, Miguel Angel, García, Margarita, Pontón, José Luis, Martínez, Marisa, Valentí, Vicente, Navarro, Matilde, Gil, Miguel, Cardenal, Felipe, Mesía, Ricard, Pérez, Xavier, Salazar, Ramón, Germà-Lluch, Josep Ramón

“…The aim of this study was to determine the safety and feasibility profile of paclitaxel (PTX) and docetaxel (DTX) in combination and the pharmacokinetic and…”
Get full text

Impact on budget of new drugs for colorectal cancer treatment by Corral, M Julieta, Clopès, Ana, Navarro, Matilde, Germà, Josep Ramon, Borràs, Josep Maria

“…To assess the impact on the medicines budget of the introduction of new treatments in colorectal cancer, as monoclonal antibodies cetuximab and bevacizumab and…”
Get more information

Does Induction Chemotherapy Still Have a Role in Larynx Preservation Strategies? The Experience of Institut Catala d'Oncologia in Stage III Larynx Carcinoma by Majem, Margarita, Mesia, Ricard, Mañós, Manel, Gomez, Joaquin, Galiana, Ramon, Cardenal, Felipe, Juan, Amparo, Montes, Ana, Perez, Francisco Javier, Nogues, Julio, Llluch, Josep Ramon Germa

“…Background: Radiotherapy with concurrent cisplatin is the standard alternative to total laryngectomy for patients with locally advanced laryngeal cancer. The…”
Get full text

Founder mutation in familial adenomatous polyposis (FAP) in the Balearic Islands by González, Sara, Blanco, Ignacio, Campos, Olga, Julià, María, Reyes, José, Llompart, Alfred, Cabeza, Elena, Germà, Josep Ramon, Obrador, Antoni, Capellá, Gabriel

“…The incidence of familial adenomatous polyposis (FAP) is approximately 7.4 per 100,000 inhabitants. APC gene mutations have been found in 60–70% of all FAP…”
Get full text

Patterns of participation in clinical trials among cancer patients: a prospective study by García Martín, Margarita, Pérez Martín, Xavier, Camiña Moncayo, Cristina, Germà Luch, Josep Ramón

Get more information

Evaluation of clinical research studies in a comprehensive cancer center by García, Margarita, Lluch, Josep Ramon Germà, Serra, Carles, Pérez, Xavier, Berenguer, Gema, Borràs, Josep Maria

“…The number of clinical trials in cancer patients has experienced an important growth during last years. However, it is difficult to find data showing this…”
Get more information

Importancia de la valoración geriátrica en las personas mayores con cáncer by Saldaña Cañada, Juana, Yuste Marco, Antonio, Germà Lluch, Josep Ramon

Get full text

Importance of geriatric assessment in the elderly with cancer by Saldaña Cañada, Juana, Yuste Marco, Antonio, Germà Lluch, Josep Ramon

Get full text

Lessons learned in the implementation of a cancer care network in Catalonia by Borras, Josep M., Boyd, Alan, Martinez-Villacampa, Mercedes, Brunet, Joan, Colomer, Ramon, Germà, Josep Ramon

Get full text

Giant parallel tube arrays (PTAs), a new type of lymphocyte inclusion by Rozman, M, Vives-Corrons, J L, Germá, J R, Colomer, D, Villamor, N, Rozman, C

“…In a 56-year-old male patient, receiving chemotherapy after radical surgery for bladder carcinoma, an unusual type of cytoplasmic inclusion was discovered in…”
Get more information